RadNet Total Assets 2010-2023 | RDNT

RadNet total assets from 2010 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
RadNet Annual Total Assets
(Millions of US $)
2023 $2,690
2022 $2,434
2021 $2,058
2020 $1,787
2019 $1,647
2018 $1,109
2017 $869
2016 $849
2015 $836
2014 $741
2013 $723
2012 $711
2011 $619
2010 $540
2009 $481
RadNet Quarterly Total Assets
(Millions of US $)
2023-12-31 $2,690
2023-09-30 $2,688
2023-06-30 $2,705
2023-03-31 $2,414
2022-12-31 $2,434
2022-09-30 $2,247
2022-06-30 $2,241
2022-03-31 $2,142
2021-12-31 $2,058
2021-09-30 $2,042
2021-06-30 $2,032
2021-03-31 $1,829
2020-12-31 $1,787
2020-09-30 $1,718
2020-06-30 $1,717
2020-03-31 $1,699
2019-12-31 $1,647
2019-09-30 $1,618
2019-06-30 $1,597
2019-03-31 $1,526
2018-12-31 $1,109
2018-09-30 $911
2018-06-30 $913
2018-03-31 $924
2017-12-31 $869
2017-09-30 $848
2017-06-30 $852
2017-03-31 $854
2016-12-31 $849
2016-09-30 $843
2016-06-30 $828
2016-03-31 $846
2015-12-31 $836
2015-09-30 $809
2015-06-30 $789
2015-03-31 $742
2014-12-31 $741
2014-09-30 $749
2014-06-30 $738
2014-03-31 $737
2013-12-31 $723
2013-09-30 $715
2013-06-30 $727
2013-03-31 $727
2012-12-31 $711
2012-09-30 $625
2012-06-30 $628
2012-03-31 $626
2011-12-31 $619
2011-09-30 $572
2011-06-30 $571
2011-03-31 $557
2010-12-31 $540
2010-09-30 $538
2010-06-30 $529
2010-03-31 $471
2009-12-31 $481
2009-09-30 $476
2009-06-30 $482
2009-03-31 $492
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.314B $1.617B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.392B 9.92
Quest Diagnostics (DGX) United States $14.915B 15.41
DaVita (DVA) United States $11.709B 15.93
Chemed (CHE) United States $8.472B 26.30
Encompass Health (EHC) United States $8.259B 21.26
Elanco Animal Health (ELAN) United States $6.552B 14.90
Option Care Health (OPCH) United States $5.147B 19.48
Amedisys (AMED) United States $2.999B 21.25
LifeStance Health (LFST) United States $2.370B 0.00
Astrana Health (ASTH) United States $2.057B 25.68
Addus HomeCare (ADUS) United States $1.548B 23.52
U.S Physical Therapy (USPH) United States $1.516B 39.30
Pennant (PNTG) United States $0.624B 36.46
Aveanna Healthcare Holdings (AVAH) United States $0.423B 0.00
Atai Life Sciences (ATAI) Germany $0.323B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.018B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.005B 0.00